The BMPR2 gene gives cells instructions for a receptor that helps control growth and repair in the blood vessels of the lungs. If this signaling is reduced, vessel walls can thicken and narrow, which can raise pressure in the lung arteries. Pathogenic variants in the BMPR2 gene are a well-known cause of heritable pulmonary arterial hypertension, although not everyone who carries one develops symptoms. When symptoms do appear, they often include shortness of breath, tiredness, dizziness, or fainting with activity.
What is a gene?
Genes are sections of DNA that hold instructions your cells use to make molecules or manage processes throughout the body. Some provide the directions for producing proteins, which are the parts of cells that do the work. Others mainly help regulate when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body develops and functions, and they can also shape how you respond to food, stress, or medications. More information on this topic is available in the LearnHub.
Overview
BMPR2Gene function
What if the gene works
The BMPR2 gene helps cells receive signals that guide growth, repair, and survival. In blood vessel walls, especially in the lungs, it supports healthy structure and helps keep cell growth from becoming excessive.
Risk
What if the gene does not work
Variants in the BMPR2 gene can raise the risk of pulmonary arterial hypertension, which increases blood pressure in the lung arteries and may cause breathlessness, fatigue, and strain on the heart. Effects can range from mild to more severe.
Treatment
What does that mean for your treatment
For a pathogenic variant in the BMPR2 gene, no treatment or drug choice based on BMPR2 is currently established in guidelines. The BMPR2 gene is an active research target in pulmonary arterial hypertension, but current medicines are chosen by the clinical picture rather than BMPR2 status alone.
Conditions associated with BMPR2
Gene function
What if the gene works
BMPR2 gene function centers on how cells receive certain growth and development signals called BMP signals. This signaling helps cells know when to grow, mature, rest, or clear away older cells. Understanding BMPR2 gene function helps explain how blood vessels and other tissues stay balanced over time.
At the cell surface, the BMPR2 gene makes part of a receptor, a protein that catches outside signals. When BMP signals arrive, that receptor passes the message inward so the cell can respond in a controlled way.
BMPR2 signaling helps cells balance growth with normal slow down cues. This steady control supports healthy turnover, so older cells can be replaced without crowding nearby tissue.
In blood vessels, the BMPR2 gene helps neighboring cells coordinate their behavior. This supports vessel walls that stay organized, flexible, and suited to the body’s usual needs, especially in the lungs.
During early development, BMPR2 signaling helps groups of cells follow shared building instructions. This lets tissues form in an orderly pattern as organs and body structures take shape.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and are part of normal human diversity, such as differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Pathogenic changes in the BMPR2 gene often reduce receptor production or weaken signaling by altering the protein’s shape, stability, or delivery to the cell surface. How BMPR2 gene variants affect protein function depends on the change: some partly reduce activity, while more disruptive variants can leave little or no working receptor. This loss of function is linked to pulmonary arterial hypertension, and stronger effects may be associated with earlier onset in some families.
How variants are linked to conditions
Pathogenic variants in the BMPR2 gene are the main known genetic cause of heritable pulmonary arterial hypertension and are also found in some people with apparently isolated pulmonary arterial hypertension. This BMPR2 gene and pulmonary arterial hypertension link is well established in human genetics. Not everyone carrying a BMPR2 variant develops the condition, but the chance is clearly higher than in the general population.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal feature of human biology. Most do not directly affect health and instead reflect natural differences among people. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences play a part. In some situations, though, one well characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For people with a BMPR2 change, risk is shaped by more than the gene alone. Pulmonary arterial hypertension is more common in women, and risk may rise with pregnancy or exposure to certain drugs or toxins linked to this condition. Not everyone with a BMPR2 change develops symptoms, so regular follow-up can help catch problems early.
Inheritance of BMPR2 variants
BMPR2-related pulmonary arterial hypertension usually follows an autosomal dominant inheritance pattern, which means a parent carrying a disease-causing variant in the BMPR2 gene can pass it to a child with a 50% chance in each pregnancy. Not everyone who inherits the variant develops symptoms, so BMPR2 gene inheritance can look different from one family member to another. Some cases happen because of a new, de novo variant, meaning it was not inherited from either parent. Men and women can both inherit and pass on BMPR2 variants.
What does my BMPR2 result mean for my family?
A harmful change in the BMPR2 gene can run in families in a dominant pattern, so close relatives such as parents, brothers, sisters, and children may also carry the same change. Not everyone who inherits a BMPR2 change will develop pulmonary arterial hypertension, but the risk is higher than usual. Because of that, family members may want to discuss whether genetic counseling or testing would be helpful for them.
Genetic information
Genetic testing
How you find out about variants
BMPR2 genetic testing for pulmonary arterial hypertension uses a blood or saliva sample to look for variants in the BMPR2 gene. A lab reads the DNA and reports whether a variant was found, often as pathogenic, likely pathogenic, or of uncertain significance.
When should I consider getting a genetic test?
Consider BMPR2 testing if you have pulmonary arterial hypertension, a condition that causes high blood pressure in the blood vessels of the lungs, especially if it started young or runs in your family. It can also help clarify risk for close relatives when a BMPR2 gene change has already been found in the family.
A genetic result is only one part of your health story
Genetic findings can provide useful information, but the amount they explain varies with the condition and the specific kind of variant. Over time, many factors, including lifestyle, environment, age, and medical history, also affect how the body functions. For some conditions, particularly those shaped by many genes, genetic information offers context rather than certainty and makes the most sense when considered with other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, it may also help put personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it through the body, or responds to it at its target, so the same treatment may work better for one person than another. This is common and can influence how much benefit someone gets from a medicine or how sensitive they are to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes can affect the way they respond to medications. It studies gene and drug patterns to help explain why the same treatment may work differently in different people. For many medicines, genes can influence both how the body handles a drug and how strong its effects are. This information can support treatment decisions that are more informed and more tailored to the individual. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the BMPR2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or adjusted. If you have questions about symptoms, treatment, or side effects, speak with your doctor.
History
Families and communities once noticed patterns that seemed to pass from parent to child. In the late 1990s and early 2000s, researchers traced many inherited cases of pulmonary arterial hypertension to the BMPR2 gene, which marked a major step in explaining why this condition can run in families. This discovery helped shift care from describing symptoms alone to recognizing a clear genetic cause in many affected families. From these first observations, research expanded steadily. Scientists then found that BMPR2 variants could also appear in people with no known family history, which broadened understanding of the condition. Over time, these findings made genetic counseling and family testing a more routine part of care for pulmonary arterial hypertension.